Largest biotech companies by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Amgen leads the 24 biotech companies ranked by cash on hand, at TRY 460.4B, ahead of BioNTech (TRY 429.5B) and Gilead Sciences (TRY 381.5B). Figures as of 18 Nov 2026, 20:27 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenTRY 460.4B
Median
TRY 21.8B
Combined market value
TRY 42.29T
Countries
5

Market values as of .

All countries
All sectors
Biotech
TRY
Clear filters
Largest biotech companies by cash on hand
#CompanyCash on hand ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareTRY 460.4BTRY 12.14TTRY 22,440.36 2.83% down 34% up United States
2BioNTechBNTX · Health CareTRY 429.5BTRY 1.05TTRY 4,216.64 1.47% down 16% down Germany
3Gilead SciencesGILD · Health CareTRY 381.5BTRY 10.6TTRY 8,549.54 0.43% down 33% up United States
4argenxARGX · Health CareTRY 176.1BTRY 3TTRY 47,659.03 0.26% down 4% up Belgium
5BiogenBIIB · Health CareTRY 151.7BTRY 1.87TTRY 12,643.88 0.03% down 49% up United States
6ModernaMRNA · Health CareTRY 130.9BTRY 4.04TTRY 9,986.10 4.25% down 755% up United States
7ImmunovantIMVT · Health CareTRY 45.5BTRY 347.6BTRY 1,679.65 0.29% up 43% up United States
8QiagenQGEN · Health CareTRY 42.3BTRY 516.9BTRY 2,502.96 0.24% down 12% up Netherlands
9Neurocrine BiosciencesNBIX · Health CareTRY 36BTRY 830.4BTRY 8,204.33 1.95% down 20% up United States
10RepligenRGEN · Health CareTRY 28.5BTRY 556.6BTRY 8,706.63 6.45% up 5% up United States
11Krystal BiotechKRYS · Health CareTRY 25BTRY 470.1BTRY 15,862.72 5.35% up 46% up United States
12ExelixisEXEL · Health CareTRY 24.3BTRY 844.7BTRY 3,461.93 0.21% up 63% up United States
13Revolution MedicinesRVMD · Health CareTRY 19.4BTRY 1.74TTRY 8,055.30 1.82% down 131% up United States
14Kymera TherapeuticsKYMR · Health CareTRY 18BTRY 523.7BTRY 6,133.83 0.09% up 87% up United States
15CRISPR TherapeuticsCRSP · Health CareTRY 17.5BTRY 198.1BTRY 2,042.00 0.85% up 21% down Switzerland
16Scholar Rock HoldingSRRK · Health CareTRY 16.3BTRY 293.4BTRY 2,405.12 5.79% up 14% up United States
17Bio-TechneTECH · Health CareTRY 13.4BTRY 576.7BTRY 3,671.22 0.23% up 26% up United States
18Kodiak SciencesKOD · Health CareTRY 10.6BTRY 322.9BTRY 4,937.83 1.15% up 396% up United States
19Twist BioscienceTWST · Health CareTRY 9.2BTRY 399.9BTRY 5,865.28 3.84% up 340% up United States
20VaxcytePCVX · Health CareTRY 8.8BTRY 468BTRY 2,956.34 1.31% down 22% up United States
21Halozyme TherapeuticsHALO · Health CareTRY 6.7BTRY 553.1BTRY 4,851.34 0.23% up 37% up United States
22ImmunityBioIBRX · Health CareTRY 4.5BTRY 360.3BTRY 338.65 7.27% up 193% up United States
23Adaptive BiotechnologiesADPT · Health CareTRY 3.6BTRY 233.3BTRY 1,441.36 0.32% up 88% up United States
24CG OncologyCGON · Health CareTRY 1.6BTRY 361BTRY 4,041.64 1.52% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4323 TRY).

Questions and answers

Which biotech companies rank first by cash on hand?

Amgen (TRY 460.4B), BioNTech (TRY 429.5B) and Gilead Sciences (TRY 381.5B) are the top three of the 24 biotech companies ranked by cash on hand as of 18 Nov 2026, 20:27 UTC.

How many biotech companies are in this ranking?

24 are ranked by cash on hand.

What are these biotech companies worth together?

The 24 biotech companies ranked by cash on hand have a combined market value of TRY 42.29T as of 18 Nov 2026, 20:27 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest biotech companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.